Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (651-660 of 927) with videos related to

Pageof 93
Sort By:
European Journal of Preventive Cardiology|March 23, 2021
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trialRafael Diaz, Qian H Li, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 16, 2011
Age- and gender-specific differences in the prognostic value of CT coronary angiographyKai Hang Yiu, Fleur R de Graaf, Joanne D Schuijf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 22, 2013
Lysine acetyltransferase PCAF is a key regulator of arteriogenesisAntonius J N M Bastiaansen, Mark M Ewing, Hetty C de Boer, et al.
Circulation|November 12, 2019
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMESJ Wouter Jukema, Laurien E Zijlstra, Deepak L Bhatt, et al.
Cardiovascular Research|December 14, 2018
Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular diseaseKjell E J Håkansson, Eveline A C Goossens, Stella Trompet, et al.
American Heart Journal|November 7, 2015
Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE studyKhalid Qaderdan, Maycel Ishak, Antonius A C M Heestermans, et al.
The American Journal of Cardiology|November 29, 2025
Intravascular Lithotripsy in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Long-Term Outcomes from the BENELUX RegistryAkshay A S Phagu, Martijn J H van Oort, Federico Oliveri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor TherapyEsther Reijnders, Patrick M Bossuyt, J Wouter Jukema, et al.
JACC. Cardiovascular Imaging|July 17, 2010
Automated quantification of stenosis severity on 64-slice CT: a comparison with quantitative coronary angiographyMark J Boogers, Joanne D Schuijf, Pieter H Kitslaar, et al.
European Heart Journal|July 20, 2022
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trialJean Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
Pageof 93

Showing results (651-660 of 927) with videos related to

Sort By:
Pageof 93
European Journal of Preventive Cardiology|March 23, 2021
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trialRafael Diaz, Qian H Li, Deepak L Bhatt, et al.
Heart (British Cardiac Society)|September 16, 2011
Age- and gender-specific differences in the prognostic value of CT coronary angiographyKai Hang Yiu, Fleur R de Graaf, Joanne D Schuijf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 22, 2013
Lysine acetyltransferase PCAF is a key regulator of arteriogenesisAntonius J N M Bastiaansen, Mark M Ewing, Hetty C de Boer, et al.
Circulation|November 12, 2019
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMESJ Wouter Jukema, Laurien E Zijlstra, Deepak L Bhatt, et al.
Cardiovascular Research|December 14, 2018
Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular diseaseKjell E J Håkansson, Eveline A C Goossens, Stella Trompet, et al.
American Heart Journal|November 7, 2015
Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE studyKhalid Qaderdan, Maycel Ishak, Antonius A C M Heestermans, et al.
The American Journal of Cardiology|November 29, 2025
Intravascular Lithotripsy in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Long-Term Outcomes from the BENELUX RegistryAkshay A S Phagu, Martijn J H van Oort, Federico Oliveri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor TherapyEsther Reijnders, Patrick M Bossuyt, J Wouter Jukema, et al.
JACC. Cardiovascular Imaging|July 17, 2010
Automated quantification of stenosis severity on 64-slice CT: a comparison with quantitative coronary angiographyMark J Boogers, Joanne D Schuijf, Pieter H Kitslaar, et al.
European Heart Journal|July 20, 2022
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trialJean Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
Pageof 93